echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Kubist Pharmaceutical Injection with datomycin has resumed imports

    Kubist Pharmaceutical Injection with datomycin has resumed imports

    • Last Update: 2021-02-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On September 26, the State Drug Administration issued the Notice on the Resumption of Imports of Datomycin for Injection by Kubist Pharmaceutical Co., Ltd.
    on August 17, 2015, the former State Food and Drug Administration issued the Notice on the Discontinuation of Imports of 3 Varieties, including Live Bilicome (No. 53 of 2015), which decided to stop the import of daptomycin for Injection, an injectable drug produced by Cubist Pharmaceuticals, Inc. Kubist Pharmaceuticals Co., Ltd. filed an application for resumption of imports and accepted a re-inspection of its manufacturing plant (OSO Biopharmaceuticals Manufacturing, LLC.) by the former State Food and Drug Administration. According to the results of the re-inspection and the company's further rectification report, the State Drug Administration considered that its rectification met the relevant requirements, decided to restore Kubist Pharmaceutical Co., Ltd. (in 2016 the company's English name changed to: Cubist Pharmaceuticals, LLC.) injection of datomycin imports, requiring the port Food and Drug Administration from the date of the announcement to resume Kubiste Pharmaceutical Co., Ltd. injection of datomycin import clearance records. (Official website of the State Drug Administration)
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.